磁共振成像参数预测高强度聚焦超声消融子宫肌瘤治疗后无灌注体积比至少90%的疗效
本研究纳入120例接受高强度聚焦超声治疗的子宫肌瘤患者,按治疗后即刻无灌注体积比分为≥90%组(72例)和<90%组(48例),采用多因素logistic回归分析预测因子。结果显示前腹壁皮下脂肪层厚度、肌瘤峰值强化、肌瘤达峰时间及肌瘤与肌层曲线下面积比值有统计学意义,可预测无灌注体积比≥90%,且无严重不良反应,抗苗勒管激素水平治疗前后无显著差异。
要点
- 前腹壁皮下脂肪层厚度、肌瘤峰值强化、达峰时间及肌瘤与肌层曲线下面积比值可预测无灌注体积比≥90%。
- 治疗后即刻无灌注体积比≥90%组72例,<90%组48例。
- 无严重不良反应,抗苗勒管激素水平治疗前与6个月随访无显著差异。
核心结论
- 基于预测模型,磁共振成像引导高强度聚焦超声治疗子宫肌瘤达到无灌注体积比至少90%在临床上似乎是可行的,且不损害患者安全。
研究设计与样本
- 研究纳入120例接受高强度聚焦超声治疗的子宫肌瘤女性,分为无灌注体积比≥90%组(n=72)和<90%组(n=48),采用多因素logistic回归分析潜在预测因子。
诊断标准与关键数值
- 多因素分析后纳入广义估计方程模型,前腹壁皮下脂肪层厚度、肌瘤峰值强化、肌瘤达峰时间及肌瘤与肌层曲线下面积比值有统计学意义,可预测无灌注体积比≥90%。
- 肌瘤与肌层T2信号强度比值无统计学意义。
- 治疗后6个月随访评估疗效,安全性评估包括不良反应和抗苗勒管激素水平变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: We aimed to investigate the role of magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound (HIFU) ablation of uterine fibroids with a nonperfused volume (NPV) ratio of at least 90%.
MATERIAL AND METHODS: A total of 120 women who underwent HIFU treatment were divided into groups 1 (n = 72) and 2 (n = 48), comprising patients with an NPV ratio of at least 90% and less than 90%, respectively. Multivariate logistic regression analyses were carried out to investigate the potential predictors of the NPV ratio of at least 90%. The NPV ratios immediately post-treatment, therapeutic efficacy at 6 months' follow-up, and safety in terms of adverse effects and changes in anti-Mullerian hormone level were assessed.
RESULTS: By introducing multiple predictors obtained from multivariate analyses into a generalized estimating equation model, the results showed that the thickness of the subcutaneous fat layer in the anterior abdominal wall, peak enhancement of fibroid, time to peak of fibroid, and the ratio of area under the curve of fibroid to myometrium were statistically significant, except T2 signal intensity ratio of fibroid to myometrium, hence predicting an NPV ratio of at least 90%. No serious adverse effects and no significant difference between the anti-Mullerian hormone levels before or 6 months post-treatment were reported.
CONCLUSIONS: The findings in this study suggest that the achievement of NPV ratio of at least 90% in magnetic resonance imaging-guided HIFU treatment of uterine fibroids based on prediction model appears clinically possible without compromising the safety of patients.
引用
- Keserci B, Duc NM. Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90. Acad Radiol. 2018. PMID: 29525424. doi:10.1016/j.acra.2018.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。